Last reviewed · How we verify

NCT04755478: OPEN THORUS

LUS to Assess Lung Injury After Lung Lobectomy

Status unknown Last updated 16 February 2021
What this trial tests

trial testing Thoracotomy in Lung Neoplasm in 30 participants. Status unknown.

Timeline
28 January 2021
Primary endpoint
30 August 2021
31 October 2021

Quick facts

Lead sponsorHospital General Universitario de Valencia
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date28 January 2021
Primary completion30 August 2021
Estimated completion31 October 2021
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital General Universitario de Valencia

Who can join

18 and older, any sex, with Lung Neoplasm or Adult ALL. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to assess whether lung ultrasound is able to detect lung injury after lung resection surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Thoracotomy

Trials testing the same drug.

Other recruiting trials for Lung Neoplasm

Currently open trials in the same condition.

Other Hospital General Universitario de Valencia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04755478.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing